Clinical Trials

Lung Neoplasms

NCT06532279 2026-04-03

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Phase 2 Recruiting

98 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Stomatitis

NCT05328505 2026-03-24

MIDAS-Prostate

80 enrolled

Phase 2 Active not recruiting

Adenocarcinoma, Prostatic Neoplasms, Recurrence

NCT04083378 2026-03-23

Software-Aided Imaging (Morfeus) for Confirming Tumor Coverage With Ablation in Patients With Liver Tumors, the COVER-ALL Study

107 enrolled 14 charts

Gastrointestinal

Malignant Liver Neoplasm

NCT01629498 2026-03-09

Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung Cancer

Phase 1/2 Active not recruiting

146 enrolled

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT00186992 2026-03-04

Radiation Therapy to Treat Musculoskeletal Tumors

202 enrolled 10 charts

Sarcoma

Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing

NCT07348887 2026-03-04

RTL-DART

Phase NA Active not recruiting

50 enrolled

Head & Neck

Squamous Cell Cancer of Head and Neck (SCCHN)

NCT01345851 2026-02-25

Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

29 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT04983095 2026-02-17

METRO

118 enrolled

Prostate Cancer Metastatic

NCT06547398 2026-02-05

Prostate Adaptive Radiation Therapy

130 enrolled

Prostatic Neoplasms

NCT06650033 2026-02-05

Pelvis ART

Phase 2 Active not recruiting

280 enrolled

Gynecologic

Pelvic Neoplasms

NCT02296684 2026-01-15

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Phase 2 Completed

67 enrolled 15 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03809000 2025-12-30

STEEL

188 enrolled 25 charts

Prostatic Neoplasms

NCT06378866 2025-12-26

DIVINE

Phase 2 Recruiting

532 enrolled

Prostatic Neoplasms

NCT03176173 2025-11-05

Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)

Phase NA Completed

45 enrolled 13 charts

CNSGastrointestinalGenitourinarySarcoma

Carcinoma, Non-Small-Cell Lung

NCT02162732 2025-11-03

Molecular-Guided Therapy for Childhood Cancer

Phase NA Completed

186 enrolled 12 charts

Carcinoma, Renal Cell, Craniopharyngioma, Ependymoma, Glioma, Carcinoma, Hepatocellular, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Choroid Plexus Neoplasms, Sarcoma, Clear Cell, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

NCT06499870 2025-10-21

Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial

Phase 2 Recruiting

50 enrolled

Phase NA Active not recruiting

Prostate Adenocarcinoma

NCT00872625 2025-09-30

Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer

Phase 1 Completed

26 enrolled

Breast

Breast Neoplasms

NCT02186470 2025-09-22

Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer

Phase NA Completed

22 enrolled

Breast

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT06549478 2025-09-17

Biology-Guided Radiation Therapy for the Treatment of Patients With Bone Metastases

Phase 1 Recruiting

24 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT02177292 2025-07-01

SIB

80 enrolled

Prostatic Neoplasms

NCT06546267 2025-06-11

PROST-ART

Recruiting

2,500 enrolled